Latest Breaking News On - சந்தோஸ் சிகிச்சை - Page 1 : comparemela.com
Cardiovascular Drugs Market Size is Projected to Reach USD
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.
Abelacimab Prevents VTE After Total Knee Arthroplasty
empr.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from empr.com Daily Mail and Mail on Sunday newspapers.
Researchers find a potentially game-changing blood clot treatment
A potentially game-changing treatment for people with, or at risk of, blood clots has been found effective by an international team of researchers led by McMaster University s Jeffrey Weitz.
Weitz s team compared abelacimab with enoxaparin as a control drug in 412 patients undergoing knee replacement surgery. Results showed that just one abelacimab injection prevents blood clots for up to a month after surgery, reducing the risk by about 80% compared with enoxaparin without increasing the risk of bleeding.
Their findings were published in The New England Journal of Medicine today, coinciding with Weitz s presentation of the research at the International Society on Thrombosis and Hemostasis 2021 Congress.
Abelacimab effective blood clot treatment, McMaster-led study shows
eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.
How a New York private equity giant became Boston’s biggest commercial landlord and biotech investor Jon Chesto © David L. Ryan/Globe Staff Blackstone recently put local executive Nick Galakatos, who runs Blackstone Life Sciences out of Cambridge, on BioMed’s board of directors.
The biggest private-equity firm in the world has been pouring money into Boston by the billions, buying up prime real estate and investing in promising biotechs.
Blackstone Group said it now owns more than $12 billion worth of real estate in the area, making it the largest commercial landlord in the region by its own estimate. The New York-based firm also has chosen Cambridge as home for its $4.6 billion life sciences investment fund, the biggest of its kind.